Abstract
Introduction/BackgroundThe KEYNOTE-021 trial showed a beneficial effect of the combination of chemotherapy and immunotherapy in non-small-cell lung cancer, since then multiple trials have studied combination of chemotherapy and immunotherapy. However,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have